Andrea Haupt|October 5, 2021Mass General Brigham vetoes controversial Alzheimer’s drug Aduhelm after internal review
Andrea Haupt|October 5, 2021AHCA Partners With Exponent, MatrixCare on New Effort to Track COVID-19 and Future Threats to Nursing Homes
Andrea Haupt|October 4, 2021UPDATED: Merck’s oral COVID-19 antiviral slashes hospitalizations, prevents deaths in phase 3, sparking race to file with FDA